Prague, Czech Republic (hybrid)
https://ecrin.org/ictd-2026
The hybrid International Clinical Trials Day (ICTD) 2026 conference "Stronger Together: Advanced Therapy Clinical Trials Without Borders" will take place on May 20, 2026.
ICTD brings together patients, health policy actors, health authorities, clinical researchers, health professionals and citizens from Europe, and beyond to discuss issues related to multinational clinical studies. Advanced Therapy Medicinal Products (ATMPs) represent a rapidly evolving area of clinical research, encompassing gene therapies, cell therapies, and tissue-engineered products designed to address diseases with high unmet medical need. Clinical research on ATMPs is characterised by complex trial designs, and unlike conventional drugs, it requires close integration of clinical protocols with GMP-compliant manufacturing, and long-term follow-up to monitor durability of effect and potential delayed risks. As a result, regulatory, ethical, and logistical considerations play a central role in ATMP clinical research and are increasingly complex when we want to work across borders.
